Lithium, Extended-Release Clinical Trials

• Open Label Study of Lithium Plus Extended-Release Carbamazepine (ERC-CBZ) for Rapid Cycling Bipolar Disorder
  ClinicalTrials.gov Identifier: NCT00325286 - Active, not recruiting
  Bipolar Disorder
  
• A Study to Evaluate the Efficacy and Safety of Adjustable Doses of Extended-Release (ER) Paliperidone Compared With Placebo, in Combination With Lithium or Valproate, to Treat Manic and Mixed Episodes in Patients With Bipolar I Disorder
  ClinicalTrials.gov Identifier: NCT00309686 - Active, not recruiting
  Affective Psychosis, Bipolar; Bipolar Disorder; Mania
  
• Study Evaluating LAMICTAL Extended-release Therapy Added To Current Seizure Treatments In Patients With Partial Seizures
  ClinicalTrials.gov Identifier: NCT00113165 - Active, not recruiting
  Epilepsy
  
• A Study to Evaluate LAMICTAL Extended-release Therapy in Patients with Primary Generalized Tonic Clonic Seizures
  ClinicalTrials.gov Identifier: NCT00104416 - Active, not recruiting
  Tonic-Clonic Seizures; Epilepsy
  
• RLS In Adults: Comparing Immediate Release Formulation With Extended Release Formulation Of Ropinirole
  ClinicalTrials.gov Identifier: NCT00314860 - Active, not recruiting
  Restless Legs Syndrome
  
• To Evaluate Ezetimibe/Simvastatin and Niacin (Extended Release Tablet) in Patients With High Cholesterol.
  ClinicalTrials.gov Identifier: NCT00271817 - Recruiting
  Hypercholesterolemia
  
• A Within-Subject Cross-Over Comparison Between Immediate Release and Extended Release Adderall
  ClinicalTrials.gov Identifier: NCT00468143 - Not yet recruiting
  Attention Deficit Hyperactivity Disorder
  
• Tolerability of MK0524A Versus Niacin Extended-Release
  ClinicalTrials.gov Identifier: NCT00378833 - Active, not recruiting
  Hypercholesterolemia; Hyperlipidemia
  
• Effect of an Investigational Compound on Tolerability of Extended Release Niacin
  ClinicalTrials.gov Identifier: NCT00376584 - Active, not recruiting
  Hypercholesteremia; Hyperlipidemia
  
• Study Evaluating Venlafaxine Extended Release in Elderly Depressed Patients
  ClinicalTrials.gov Identifier: NCT00247429 - Active, not recruiting
  Depressive Syndrome; Anxiety
  
• Comparison of Combination Olanzapine+Lithium or Chlorpromazine+Lithium in Treatment of First Manic Episode With Psychotic Features
  ClinicalTrials.gov Identifier: NCT00202293 - Recruiting
  Bipolar Disorder; Schizoaffective Disorder
  
• Pioglitazone Vs Placebo in Combination With Niacin Extended Release on Low HDL
  ClinicalTrials.gov Identifier: NCT00300365 - Recruiting
  Metabolic Syndrome
  
• Study of Extended Release Niacin/Laropiprant on Lipids
  ClinicalTrials.gov Identifier: NCT00479388 - Recruiting
  Primary Hypercholesterolemia; Mixed Dyslipidemia
  
• Evaluate Efficacy and Safety of Tolterodine Extended Release Capsule Compared with Tolterodine Immediate Release Tablet in Patients with Symptoms of Overactive Bladder
  ClinicalTrials.gov Identifier: NCT00139724 - Completed
  Overactive bladder
  
• Conversion To Monotherapy With Lamictal Extended Release Tablets For Treatment Of Partial Epilepsy
  ClinicalTrials.gov Identifier: NCT00355082 - Active, not recruiting
  Epilepsy, Partial
  
• A Study to Evaluate the Efficacy and Safety of Three Fixed Doses of Extended-Release Paliperidone in Subjects With Bipolar I Disorder
  ClinicalTrials.gov Identifier: NCT00299715 - Active, not recruiting
  Bipolar Disorder; Mood Disorders
  
• PRoFESS - Prevention Regimen For Effectively Avoiding Second Strokes
  ClinicalTrials.gov Identifier: NCT00153062 - Active, not recruiting
  Cerebrovascular Accident
  
• Severe Mood and Behavioral Dysregulation in Children: Pathophysiology and Treatment with Lithium
  ClinicalTrials.gov Identifier: NCT00025935 - Recruiting
  Mood Disorder
  
• Study to Measure the Safety of Paliperidone ER (Extended-Release) in Patients With Liver Disease
  ClinicalTrials.gov Identifier: NCT00535145 - Recruiting
  Schizophrenia; Psychotic Disorders; Schizoaffective Disorder
  
• 3 Fixed Dosages of Extended Release OROS Paliperidone and Olanzapine in the Treatment of Subjects with Schizophrenia
  ClinicalTrials.gov Identifier: NCT00078039 - Active, not recruiting
  Schizophrenia
  
• Study of Gabapentin Extended Release (G-ER) in the Treatment of Vasomotor (Hot Flashes/Hot Flushes) Symptoms in Postmenopausal Women
  ClinicalTrials.gov Identifier: NCT00511953 - Active, not recruiting
  Hot Flashes
  
• Extended Release OROS Paliperidone in Treatment of Schizophrenia (double blind, placebo-controlled trial, with Olanzapine arm)
  ClinicalTrials.gov Identifier: NCT00083668 - Active, not recruiting
  Schizophrenia
  
• Comparative Study of the Effect of Ezetimibe Versus Extended-Release Niacin on Atherosclerosis
  ClinicalTrials.gov Identifier: NCT00397657 - Recruiting
  Atherosclerosis
  
• Lamotrigine Extended-Release in Elderly Patients With Epilepsy
  ClinicalTrials.gov Identifier: NCT00516139 - Recruiting
  Epilepsy
  
• Improving Hispanic Retention in Antidepressant Therapy
  ClinicalTrials.gov Identifier: NCT00057642 - Active, not recruiting
  Depression; Depressive Disorder
  
• A Study of the Efficacy and Safety of One Dosage of Paliperidone Extended Release (ER) in Treating Patients With Schizophrenia
  ClinicalTrials.gov Identifier: NCT00524043 - Recruiting
  Schizophrenia
  
• Study to Evaluate Symptoms in Patients Treated With Nebivolol or Metoprolol Extended-Release (ER) for Hypertension
  ClinicalTrials.gov Identifier: NCT00547300 - Recruiting
  Hypertension
  
• Rosiglitazone (Extended Release Tablets) As Adjunctive Therapy For Subjects With Mild To Moderate Alzheimer's Disease
  ClinicalTrials.gov Identifier: NCT00348309 - Recruiting
  Alzheimer Disease
  
• A Trial to Explore the Tolerability, Safety and Effectiveness of Paliperidone ER (Extended Release) Flexible Dosing in Patients With Schizophrenia
  ClinicalTrials.gov Identifier: NCT00460512 - Recruiting
  Schizophrenia
  
• Peg-Intron/Ribavirin in G 1 HCV for Non-Extended Versus 24 Week Extended Treatment After 24 Weeks (Study P04144AM)
  ClinicalTrials.gov Identifier: NCT00202839 - Active, not recruiting
  Hepatitis C, Chronic
  
• Depakote Extended Release (ER) Versus Seroquel for Agitated Behaviors in Nursing Home Care Unit Patients With Dementia
  ClinicalTrials.gov Identifier: NCT00315900 - Recruiting
  Agitation; Dementia
  
• A Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Paliperidone Extended Release (ER) in the Treatment of Schizophrenia in Adolescent Patients.
  ClinicalTrials.gov Identifier: NCT00518323 - Recruiting
  Schizophrenia
  
• A Trial to Explore the Tolerability, Safety and Treatment Response of the Antipsychotic Paliperidone ER (Extended Release) Using Flexible Dosing in Patients With Acute Schizophrenia
  ClinicalTrials.gov Identifier: NCT00566631 - Recruiting
  Schizophrenia
  
• A Study to Evaluate the Efficacy and Safety of Flexible Doses of Extended-Release (ER) Paliperidone Compared With Flexible Doses of Quetiapine and Placebo in Patients With Bipolar I Disorder
  ClinicalTrials.gov Identifier: NCT00309699 - Active, not recruiting
  Bipolar Disorder; Mood Disorders
  
• Rosiglitazone (Extended Release Tablets) As Adjunctive Therapy In Subjects With Mild To Moderate Alzheimer's Disease
  ClinicalTrials.gov Identifier: NCT00348140 - Recruiting
  Alzheimer's Disease
  
• Rosiglitazone (Extended Release Tablets) Monotherapy In Subjects With Mild To Moderate Alzheimer's Disease
  ClinicalTrials.gov Identifier: NCT00428090 - Recruiting
  Alzheimer's Disease
  
• Exercise vs. Extended-Release Niacin in Patients With Coronary Heart Disease and Low HDL Cholesterol: Effect on Lipid Profile and Endothelial Function
  ClinicalTrials.gov Identifier: NCT00298909 - Recruiting
  Coronary Disease; Hypolipoproteinemia
  
• Open-Label Study of Flexible-Dose Paliperidone ER (Extended Release) to Treat Adolescent Schizophrenia.
  ClinicalTrials.gov Identifier: NCT00488319 - Recruiting
  Dementia Praecox.; Schizophrenia; Psychotic Disorders; Schizophrenic Disorders
  
• An Open-Label Extension Study With Flexible Dosing of Extended-Release (ER) Tapentadol (CG5503) to Treat Patients With Moderate to Severe Chronic Pain
  ClinicalTrials.gov Identifier: NCT00487435 - Recruiting
  Low Back Pain; Pain; Osteoarthritis
  
• Patients With Epilepsy Taking LAMICTAL Immediate-Release Who Switch To Extended-Release Formulation And Vice Versa
  ClinicalTrials.gov Identifier: NCT00264615 - Completed
  Epilepsy
  
• Evaluation of Effectiveness and Safety of Flexible-Dose Paliperidone Extended Release in Patients With Schizoaffective Disorder.
  ClinicalTrials.gov Identifier: NCT00412373 - Recruiting
  Psychotic Disorder; Schizoaffective Disorder
  
• Evaluation of Effectiveness and Safety of Paliperidone Extended Release in Patients With Schizoaffective Disorder.
  ClinicalTrials.gov Identifier: NCT00397033 - Recruiting
  Schizoaffective Disorder; Psychotic Disorder
  
• Carbamazepine Extended-Release for the Treatment of Bipolar Depression
  ClinicalTrials.gov Identifier: NCT00203567 - Recruiting
  Bipolar Depression
  
• Extended Release Nifedipine Treatment as Maintenance Tocolysis to Prevent Preterm Delivery
  ClinicalTrials.gov Identifier: NCT00525486 - Not yet recruiting
  Preterm Labor
  
• A Study to Evaluate the Effectiveness and Safety of Tapentadol(CG5503) Extended Release (ER) in Patients With Moderate to Severe Chronic Low Back Pain
  ClinicalTrials.gov Identifier: NCT00449176 - Recruiting
  Low Back Pain
  
• Bipolar II Depression: Lithium, SSRI, or the Combination
  ClinicalTrials.gov Identifier: NCT00276965 - Recruiting
  Bipolar II Depression
  
• A Phase III Trial to Evaluate the Effectiveness and Safety of Tapentadol(CG5503) Extended Release (ER) in Patients With Moderate to Severe Chronic Pain Due to Osteoarthritis of the Knee
  ClinicalTrials.gov Identifier: NCT00421928 - Recruiting
  Pain; Osteoarthritis, Knee
  
• A Safety and Efficacy Study for Tapentadol (CG5503) Extended Release for Patients With Painful Diabetic Peripheral Neuropathy
  ClinicalTrials.gov Identifier: NCT00455520 - Recruiting
  Diabetic Polyneuropathy; Diabetic Neuropathy: Painful
  
• A Study to Evaluate the Effectiveness and Safety of Extended-Release (ER) Paliperidone Compared With Placebo in Delaying the Recurrence of Symptoms in Bipolar I Disorder
  ClinicalTrials.gov Identifier: NCT00490971 - Recruiting
  Manic-Depressive Psychosis; Affective Disorder, Bipolar; Bipolar Disorder; Depression, Bipolar; Manic Disorder
  
• Enoximone Plus Extended-Release Metoprolol Succinate in Subjects with Advanced Chronic Heart Failure
  ClinicalTrials.gov Identifier: NCT00077948 - Active, not recruiting
  Heart Failure, Congestive
  
• Compliance With Once-Daily Divalproex Extended-Release Tablets (Depakote-ER) Versus Multiple-Daily Dose Valproic Acid Capsules (Depakene) in Epilepsy:
  ClinicalTrials.gov Identifier: NCT00356018 - Not yet recruiting
  Epilepsy
  
• Effect of Niacin Extended Release and Lovastatin tablets on Walking in Patients with Intermittent Claudication (ICPOP)
  ClinicalTrials.gov Identifier: NCT00062556 - Completed
  Intermittent Claudication; Peripheral Vascular Disease
  
• A Study To Investigate The Antidepressant Effect Of Lamotrigine In Patients With Bipolar Disorder Using Lithium
  ClinicalTrials.gov Identifier: NCT00224510 - Active, not recruiting
  Bipolar Depression
  
• A Study to Look at the Efficacy and Safety of Keppra® Extended Release
  ClinicalTrials.gov Identifier: NCT00368069 - Completed
  Epilepsy
  
• A Study to Evaluate Long-Term Safety of Multiple Doses of Tapentadol(CG5503) Prolonged-Release (PR) and Oxycodone Controlled-Release (CR) in Patients With Chronic Pain
  ClinicalTrials.gov Identifier: NCT00361504 - Active, not recruiting
  Osteoarthritis; Sciatica; Pain Assessment; Arthralgia
  
• Behavioral Naltrexone Therapy (BNT) for Promoting Adherence to Oral Naltrexone (BNT-Oral) vs Extended Release Injectable Depot Naltrexone (Depot-BNT); a Randomized Trial. A Free Treatment for Opiate Abuse.
  ClinicalTrials.gov Identifier: NCT00577408 - Recruiting
  Opiate Dependence; Heroin Dependence
  
• Residual Effects of Zolpidem Tartrate Extended Release and Eszopiclone Vs Placebo
  ClinicalTrials.gov Identifier: NCT00283790 - Completed
  Insomnia
  
• Lithium for the Treatment of Pediatric Mania
  ClinicalTrials.gov Identifier: NCT00442039 - Recruiting
  Bipolar I Disorder Without Psychotic Symptoms
  
• Safety and Pharmacokinetics Study of Oral Lithium in Patients With Chronic Spinal Cord Injury
  ClinicalTrials.gov Identifier: NCT00431171 - Active, not recruiting
  Spinal Cord Injuries
  
• Effectiveness of Lithium and Valproate in Treating High-Risk Bipolar Disorder
  ClinicalTrials.gov Identifier: NCT00563992 - Active, not recruiting
  Bipolar Disorder
  
• Study of the Effectiveness and Tolerability of OROS Hydromorphone HCI SR(Slow-Release) Tablets and Immediate-Release Hydromorphone Tablets in Patients With Chronic Pain
  ClinicalTrials.gov Identifier: NCT00410943 - Active, not recruiting
  Pain
  
• Lithium Versus Divalproex for Treating Pediatric Bipolar Disorder
  ClinicalTrials.gov Identifier: NCT00221429 - Active, not recruiting
  Bipolar Disorder
  
• Safety and Efficacy Study of Lithium in Bipolar Disorder
  ClinicalTrials.gov Identifier: NCT00422331 - Active, not recruiting
  Bipolar Disorder; Mania
  
• Study Evaluating Venlafaxine Extended-Release in Depressed and Anxious Patients
  ClinicalTrials.gov Identifier: NCT00546923 - Completed
  Anxiety Disorders; Depression
  
• Combination Therapy for the Treatment of Bipolar Disorders
  ClinicalTrials.gov Identifier: NCT00063362 - Active, not recruiting
  Bipolar Disorder
  
• Lithium and Divalproex for the Treatment of Comorbid Rapid Cycling Bipolar Disorder and Substance Abuse Disorder
  ClinicalTrials.gov Identifier: NCT00194129 - Active, not recruiting
  Bipolar Disorder
  
• Study of Divalproex Extended Release Monotherapy in Ambulatory Bipolar Spectrum Disorder With Moderate-to-Severe Hypomania or Mild Mania
  ClinicalTrials.gov Identifier: NCT00278772 - Recruiting
  Bipolar Spectrum Disorder With Moderate-to- Severe Hypomania or Mild Mania
  
• 3-Week Study to Evaluate Efficacy and Safety of Ziprasidone With Either Lithium or Divalproex in Acutely Manic Subjects
  ClinicalTrials.gov Identifier: NCT00312494 - Recruiting
  Bipolar Disorder
  
• Treatment and Outcome of Early Onset Bipolar Disorder
  ClinicalTrials.gov Identifier: NCT00048802 - Active, not recruiting
  Bipolar Disorder
  
• Trial of Analgesia With Lidocaine or Extended-Release Oxycodone for Neuropathic Pain Treatment in Multiple Sclerosis
  ClinicalTrials.gov Identifier: NCT00414453 - Not yet recruiting
  Neuropathic Pain; Chronic Pain; Multiple Sclerosis
  
• Dose Ranging, Safety and Tolerability of TOPROL-XL® Extended-Release Tablets in Hypertensive Pediatric Subjects
  ClinicalTrials.gov Identifier: NCT00255528 - Completed
  Hypertension
  
• Antipsychotic Medication Extended Dosing Study
  ClinicalTrials.gov Identifier: NCT00431574 - Active, not recruiting
  Schizophrenia
  
• Lithium in Treating Patients With Acute Intestinal Graft-Versus-Host Disease After Donor Stem Cell Transplant
  ClinicalTrials.gov Identifier: NCT00408681 - Recruiting
  Cancer
  
• Acute Treatment of Bipolar II Depression
  ClinicalTrials.gov Identifier: NCT00074776 - Active, not recruiting
  Bipolar Depression
  
• Clinical Performance of Extended Wear Silicone Hydrogel Lenses
  ClinicalTrials.gov Identifier: NCT00441233 - Active, not recruiting
  Myopia
  
• Pharmacokinetics of Immediate-Release vs. Delayed-Release Omeprazole in Gastroparesis
  ClinicalTrials.gov Identifier: NCT00492622 - Recruiting
  Gastroparesis; Gastroesophageal Reflux Disease
  
• An Effectiveness and Safety Study of Acetaminophen Extended Release Caplets in Treating Muscle Aches and Soreness That Occur After a Marathon Race
  ClinicalTrials.gov Identifier: NCT00240851 - Completed
  Pain
  
• Efficacy, Tolerability and Safety of Dexmethylphenidate HCl Extended-Release Capsules in Children With Attention-Deficit/Hyperactivity Disorder
  ClinicalTrials.gov Identifier: NCT00301236 - Completed
  ADHD, ADD
  
• A Study Comparing the Effectiveness and Safety of Extended Release Tramadol Versus Placebo for the Treatment of Osteoarthritis (OA) of the Knee
  ClinicalTrials.gov Identifier: NCT00348010 - Completed
  Chronic Pain
  
• A Study Comparing the Analgesic Efficacy and Safety of Extended Release Hydrocodone/Acetaminophen (Vicodin® CR)and Placebo in Subjects With Osteoarthritis
  ClinicalTrials.gov Identifier: NCT00404183 - Completed
  Pain
  
• Extended Follow-up of Columbia, MO Serum Bank Participants
  ClinicalTrials.gov Identifier: NCT00340210 - Active, not recruiting
  Cancer; Morbidity
  
• Comparative Study of Modified Release (MR) Tacrolimus/MMF in de novo Kidney Transplant Recipients
  ClinicalTrials.gov Identifier: NCT00064701 - Active, not recruiting
  Kidney Transplantation
  
• Open-Label, Randomized Study Evaluating Treatment With Venlafaxine Extended-Release Plus Diaologues Time to Talk Program
  ClinicalTrials.gov Identifier: NCT00401726 - Completed
  Depressive Disorder, Major
  
• Relapse Prevention for Bipolar Type-II Disorder
  ClinicalTrials.gov Identifier: NCT00044616 - Active, not recruiting
  Bipolar Disorder; Depression
  
• Cognitive Effects of Darifenacin and Oxybutynin Extended Release in Volunteers Aged 60 and Over
  ClinicalTrials.gov Identifier: NCT00170768 - Completed
  Healthy Volunteers
  
• Study Evaluating Antibiotic Utilization Measures and Control of Extended-Spectrum-Lactamases (ESBLs)
  ClinicalTrials.gov Identifier: NCT00254696 - Active, not recruiting
  Bacterial Infection
  
• The Safety and Efficacy of Divalproex Sodium Extended-Release Tablets in Migraine Prophylaxis: A Study in Adolescents
  ClinicalTrials.gov Identifier: NCT00195741 - Completed
  Migraine
  
• An Effectiveness and Safety Study of Acetaminophen Extended Release Caplets in the Treatment of Osteoarthritis of the Hip or Knee.
  ClinicalTrials.gov Identifier: NCT00240799 - Completed
  Osteoarthritis
  
• Evaluation of Effectiveness and Safety of Paliperidone ER (Extended-Release) Compared With Quetiapine in Patients With Schizophrenia
  ClinicalTrials.gov Identifier: NCT00334126 - Completed
  Schizophrenia
  
• A Study of Extended-Release Hydrocodone/Acetaminophen (Vicodin CR®) in Subjects With Acute Pain Following Bunionectomy
  ClinicalTrials.gov Identifier: NCT00402792 - Completed
  Pain
  
• An Effectiveness and Safety Study of Two Doses of Acetaminophen Extended Release Caplets in the Treatment of Osteoarthritis of the Hip or Knee
  ClinicalTrials.gov Identifier: NCT00240786 - Completed
  Osteoarthritis
  
• Efficacy Study of Extended-Release Niacin/Lovastatin Versus Usual Care
  ClinicalTrials.gov Identifier: NCT00345657 - Completed
  Hyperlipidemia; Mixed Hyperlipidemia; Dyslipidemia
  
• Open-Label Study to Evaluate the Efficacy and Safety of an Extended-Cycle, Low Dose Combination Oral Contraceptive
  ClinicalTrials.gov Identifier: NCT00196326 - Active, not recruiting
  Contraception
  
• Study Intended to Show That the VISTAKON Contact Lens is Safe and Effective for Use on an Extended-Wear Basis for Up to 7 Days and 6 Nights at a Time.
  ClinicalTrials.gov Identifier: NCT00241280 - Active, not recruiting
  Myopia
  
• A Randomised, Crossover Study Comparing the Biochemical and Platelet Effects of Modified-Release Dipyridamole/Aspirin (200mg/25 Mg Bd; Asasantin Retard®) with Aspirin (75 Mg Qd) in Coronary Artery Disease Patients with Aspirin Resistance Manifesting
  ClinicalTrials.gov Identifier: NCT00129038 - Active, not recruiting
  Coronary Arteriosclerosis
  
• A Comparison of Ropinirole Immediate Release With Ropinirole Prolonged Release in Patients With Advanced Parkinson's
  ClinicalTrials.gov Identifier: NCT00331149 - Recruiting
  Parkinson's Disease
  
• A Study Comparing the Analgesic Activity of Extended Release Hydrocodone/Acetaminophen (Vicodin® CR) and Placebo in Subjects With Pain Following Bunionectomy Surgery
  ClinicalTrials.gov Identifier: NCT00404391 - Completed
  Pain
  
• Indicated Prevention of Psychotic Disorders With Low-Dose Lithium
  ClinicalTrials.gov Identifier: NCT00202306 - Recruiting
  Schizophrenia; Bipolar Disorder; Psychotic Disorders
  
• Genetic Studies of Psychiatric Illness
  ClinicalTrials.gov Identifier: NCT00252577 - Recruiting
  Bipolar Disorder
  
• A Randomized, Active-Controlled, Double-Blind, Parallel-Goup Study of the Efficacy and Safety of Extended Release(ER) Paliparidone in the Treatment of Schizophrenia
  ClinicalTrials.gov Identifier: NCT00350467 - Completed
  Acute Schizophrenia